![](https://www.molecular-medicine-israel.co.il/wp-content/uploads/2014/11/leukaemia-300x182.jpg)
Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells
Highlights Summary Relapse of acute myeloid leukemia (AML) remains a significant concern due to persistent leukemia-initiating stem cells (LICs) that are typically not targeted by